Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors: An Evolving Paradigm of Molecularly Targeted Therapy
Crossref DOI link: https://doi.org/10.1007/s40291-016-0208-1
Published Online: 2016-05-24
Published Print: 2016-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ali, Mohamed A. M.
Text and Data Mining valid from 2016-05-24